Ikarian Capital, LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$37,576
-99.3%
11
-100.0%
0.01%
-99.4%
Q2 2023$5,216,212
-9.2%
135,486
-15.6%
0.83%
-36.2%
Q1 2023$5,743,793
-9.2%
160,4860.0%1.30%
-14.7%
Q4 2022$6,327,963
+9.2%
160,4860.0%1.53%
+32.2%
Q3 2022$5,794,000
-20.4%
160,486
-33.0%
1.16%
-13.0%
Q2 2022$7,283,000
-0.5%
239,4410.0%1.33%
+37.9%
Q1 2022$7,320,000
+30.8%
239,441
+33.7%
0.96%
+15.5%
Q4 2021$5,597,000
-68.3%
179,138
-84.5%
0.83%
-32.9%
Q3 2021$17,635,000
+15.5%
1,154,138
+40.8%
1.24%
+0.6%
Q2 2021$15,262,000
+7.8%
819,706
+3.7%
1.23%
+159.2%
Q1 2021$14,154,000
+312.4%
790,676
+254.3%
0.48%
+215.2%
Q4 2020$3,432,000
+38.9%
223,1730.0%0.15%
-15.6%
Q3 2020$2,470,000
-33.9%
223,173
-25.2%
0.18%
-39.9%
Q2 2020$3,739,000
-25.7%
298,173
-32.8%
0.30%
-21.2%
Q1 2020$5,030,000
+57.6%
443,582
+82.2%
0.38%
-26.9%
Q4 2019$3,192,000243,4700.52%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders